Theragene Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Theragene Pharmaceuticals General Information

Description

Developer of immunotherapy and gene therapy technologies designed to create cancer and cardiology treatments. The company's technologies increase the body's ability to recognize and fight tumor cells, and its gene therapy platform utilizes adeno-associated virus technology for the treatment of cardiovascular diseases, enabling physicians to give patients a safe alternative to traditional treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 6150 Lusk Boulevard
  • Suite B 201
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 6150 Lusk Boulevard
  • Suite B 201
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theragene Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Sep-2025 Completed Generating Revenue
3. Later Stage VC (Series A) 13-Dec-2017 Completed Generating Revenue
2. Seed Round 11-Aug-2015 $200K $548K Completed Generating Revenue
1. Seed Round 13-Mar-2014 $348K $348K Completed Generating Revenue
To view Theragene Pharmaceuticals’s complete valuation and funding history, request access »

Theragene Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapy and gene therapy technologies designed to create cancer and cardiology treatments. The compan
Biotechnology
San Diego, CA

Maastricht, Netherlands
 

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Theragene Pharmaceuticals Competitors (102)

One of Theragene Pharmaceuticals’s 102 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
AnTolRx Formerly VC-backed Cambridge, MA
Meditope Biosciences Formerly VC-backed Pasadena, CA
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Iovance Biotherapeutics Corporation San Carlos, CA
You’re viewing 5 of 102 competitors. Get the full list »

Theragene Pharmaceuticals Patents

Theragene Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120021926-A1 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban Active 22-Jan-2009
US-8431356-B2 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban Active 22-Jan-2009
EP-1948246-A2 Stem cell factor therapy for tissue injury Active 14-Nov-2005
EP-1948246-A4 Stem cell factor therapy for tissue injury Active 14-Nov-2005
EP-1948246-B1 Stem cell factor therapy for tissue injury Active 14-Nov-2005 A61K48/005
To view Theragene Pharmaceuticals’s complete patent history, request access »

Theragene Pharmaceuticals FAQs

  • When was Theragene Pharmaceuticals founded?

    Theragene Pharmaceuticals was founded in 2011.

  • Where is Theragene Pharmaceuticals headquartered?

    Theragene Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Theragene Pharmaceuticals in?

    Theragene Pharmaceuticals’s primary industry is Biotechnology.

  • Is Theragene Pharmaceuticals a private or public company?

    Theragene Pharmaceuticals is a Private company.

  • What is Theragene Pharmaceuticals’s current revenue?

    The current revenue for Theragene Pharmaceuticals is .

  • How much funding has Theragene Pharmaceuticals raised over time?

    Theragene Pharmaceuticals has raised $548K.

  • Who are Theragene Pharmaceuticals’s competitors?

    Cristal Therapeutics, AnTolRx, Meditope Biosciences, Oxford Biotherapeutics, and Iovance Biotherapeutics are some of the 102 competitors of Theragene Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process